View in EDS HTML Full Text PDF Full Text

aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis.

Saved in:
Bibliographic Details
Title: aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis.
Authors: Zhou NQ; Department of Ultrasonography, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China., Fang ZX; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China., Huang N; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China., Zuo Y; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China., Qiu Y; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China., Guo LJ; Department of Oncology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China., Song P; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China., Xu J; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China., Wan GR; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China., Tian XQ; Department of Ultrasonography, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China., Yin YL; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China., Li P; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2021 Apr 27; Vol. 12, pp. 607785. Date of Electronic Publication: 2021 Apr 27 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33986662
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhou+NQ%22">Zhou NQ</searchLink>; Department of Ultrasonography, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Fang+ZX%22">Fang ZX</searchLink>; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Huang+N%22">Huang N</searchLink>; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Zuo+Y%22">Zuo Y</searchLink>; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Qiu+Y%22">Qiu Y</searchLink>; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Guo+LJ%22">Guo LJ</searchLink>; Department of Oncology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Song+P%22">Song P</searchLink>; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Xu+J%22">Xu J</searchLink>; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Wan+GR%22">Wan GR</searchLink>; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Tian+XQ%22">Tian XQ</searchLink>; Department of Ultrasonography, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Yin+YL%22">Yin YL</searchLink>; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Li+P%22">Li P</searchLink>; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.; Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China.; College of Pharmacy, Xinxiang Medical University, Xinxiang, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2021 Apr 27; Vol. 12, pp. 607785. <i>Date of Electronic Publication: </i>2021 Apr 27 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33986662
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2021.607785
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 607785
    Titles:
      – TitleFull: aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhou NQ
      – PersonEntity:
          Name:
            NameFull: Fang ZX
      – PersonEntity:
          Name:
            NameFull: Huang N
      – PersonEntity:
          Name:
            NameFull: Zuo Y
      – PersonEntity:
          Name:
            NameFull: Qiu Y
      – PersonEntity:
          Name:
            NameFull: Guo LJ
      – PersonEntity:
          Name:
            NameFull: Song P
      – PersonEntity:
          Name:
            NameFull: Xu J
      – PersonEntity:
          Name:
            NameFull: Wan GR
      – PersonEntity:
          Name:
            NameFull: Tian XQ
      – PersonEntity:
          Name:
            NameFull: Yin YL
      – PersonEntity:
          Name:
            NameFull: Li P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 04
              Text: 2021 Apr 27
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1